Fibroblast growth factor 21 (FGF21) is produced by tissues involved in metabolism, such as the liver, adipose tissues, skeletal muscle, and pancreas, and has been suggested to improve metabolic diseases and induce weight loss in humans and mice [15–17]. Here, FGF21 is linked to metabolic disease.